title: Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism.
authors.affiliation: Department of Medicine, Royal Postgraduate Medical School, London.
authors.forename: S
authors.initials: S
authors.lastname: Levi
authors.forename: K
authors.initials: K
authors.lastname: Beardshall
authors.forename: I
authors.initials: I
authors.lastname: Swift
authors.forename: W
authors.initials: W
authors.lastname: Foulkes
authors.forename: R
authors.initials: R
authors.lastname: Playford
authors.forename: P
authors.initials: P
authors.lastname: Ghosh
authors.forename: J
authors.initials: J
authors.lastname: Calam
mesh_terms: D000863:Antacids / Q000627:therapeutic use; D002167:Campylobacter / Q000302:isolation & purification; D002169:Campylobacter Infections / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D004381:Duodenal Ulcer / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D005755:Gastrins / Q000097:blood*; D005756:Gastritis / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use; D011706:Pyloric Antrum / Q000382:microbiology
chemical_list: D000863:Antacids; D005755:Gastrins; D009942:Organometallic Compounds; D008795:Metronidazole; C002791:bismuth tripotassium dicitrate